Publicacións en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (16)

2024

  1. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers

    Journal of Translational Medicine, Vol. 22, Núm. 1

2023

  1. Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials

    The American journal of cardiology, Vol. 205, pp. 321-324

  2. The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events

    Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611

2022

  1. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

  2. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 559-567

2021

  1. Long-term prognosis of women with Brugada syndrome and electrophysiological study

    Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671

  2. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

2020

  1. Estimation of the major cardiovascular events prevention with Inclisiran

    Atherosclerosis, Vol. 313, pp. 76-80

2018

  1. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm

    Europace, Vol. 20, Núm. 5, pp. 851-858

2016

  1. Evaluación comparativa de cuatro puntuaciones de riesgo para predecir la mortalidad de pacientes con desfibrilador automático implantable en prevención primaria

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1033-1041

  2. Evolución de los pacientes portadores de desfibrilador como prevención primaria tras un episodio de tormenta arrítmica

    Archivos de Cardiologia de Mexico, Vol. 86, Núm. 1, pp. 26-34

  3. La hiponatremia como marcador de riesgo en pacientes sometidos a implante de desfibrilador en prevención primaria

    Revista Colombiana de Cardiologia, Vol. 23, Núm. 1, pp. 26-34

  4. Primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: Results of a Spanish multicentre study

    Europace, Vol. 18, Núm. 8, pp. 1203-1210

  5. Research update for articles published in EJCI in 2014

    European Journal of Clinical Investigation, Vol. 46, Núm. 10, pp. 880-894

2015

  1. Analyses of inappropriate shocks in a Spanish ICD primary prevention population: Predictors and prognoses

    International Journal of Cardiology, Vol. 195, pp. 188-194

2011

  1. Anticoagulation prescription in atrial fibrillation

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 10, pp. 1473-1479